Ufp Technologies (UFPT) Non-Current Assets (2010 - 2026)
Ufp Technologies' (UFPT) quarterly Non-Current Assets came in at $450.6 million in Q1 2026, up 3.16% YoY from $436.8 million in Q1 2025, and down 0.77% on a QoQ basis from $454.1 million in Q4 2025.
Ufp Technologies (UFPT) Non-Current Assets (2010 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has 17 years of Non-Current Assets data on file, last reported at $450.6 million in Q1 2026.
- Quarterly Non-Current Assets rose 3.16% year-over-year to $450.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 14.93% YoY) and the FY2025 annual result came in at $454.1 million, up 4.61% from the prior year.
- Non-Current Assets slipped to $450.6 million in Q1 2026, from $454.1 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $454.8 million in Q3 2025 to a low of $257.1 million in Q1 2024.
- A 5-year average of $336.8 million and a median of $264.9 million in 2022 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets surged 105.9% — and 2023, when it declined 3.13%.
- Tracing UFPT's Non-Current Assets over 5 years: stood at $261.8 million in 2022, then retreated by 0.89% to $259.5 million in 2023, then soared by 67.26% to $434.0 million in 2024, then rose by 4.61% to $454.1 million in 2025, then dropped by 0.77% to $450.6 million in 2026.
- The last three Non-Current Assets figures came in at $450.6 million (Q1 2026), $454.1 million (Q4 2025), and $454.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Ufp Technologies | 2.34 Bn | 2.33 Bn | 50.92 Mn | 447.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 447.02 Mn |
| Mar 31, 2026 | 450.58 Mn |
| Dec 31, 2025 | 454.08 Mn |
| Sep 30, 2025 | 454.85 Mn |
| Jun 30, 2025 | 443.27 Mn |
| Mar 31, 2025 | 436.76 Mn |
| Dec 31, 2024 | 434.05 Mn |
| Sep 30, 2024 | 437.50 Mn |
| Jun 30, 2024 | 260.24 Mn |
| Mar 31, 2024 | 257.14 Mn |
| Dec 31, 2023 | 259.50 Mn |
| Sep 30, 2023 | 259.34 Mn |
| Jun 30, 2023 | 260.92 Mn |
| Mar 31, 2023 | 263.87 Mn |
| Dec 31, 2022 | 261.85 Mn |
| Sep 30, 2022 | 258.07 Mn |
| Jun 30, 2022 | 269.35 Mn |
| Mar 31, 2022 | 264.91 Mn |
| Dec 31, 2021 | 246.81 Mn |
| Sep 30, 2021 | 129.55 Mn |